Skip to main content

Table 2 Percent prevalence of antimicrobial sensitivity phenotypes in urine isolates as determined by the disk diffusion method

From: High prevalence of multidrug resistant Enterobacteriaceae isolated from outpatient urine samples but not the hospital environment in Bo, Sierra Leone

Species

No.

Phenotype

Antibiotica

ESBL

ATM

CAZ

CIP

IMP

TGC

C

D

G

GM

K

SAM

Citrobacter freundii

22

R

95.5

68.2

100.0

0.0

0.0

68.2

77.3

100.0

100.0

45.5

81.8

81.8

I

0.0

31.8

0.0

22.7

40.9

4.5

22.7

0.0

0.0

50.0

18.2

S

4.5

0.0

0.0

77.3

59.1

27.3

0.0

0.0

0.0

4.5

0.0

Enterobacter sp./Leclercia sp.

4

R

50.0

75.0

75.0

50.0

0.0

100.0

25.0

100.0

100.0

50.0

0.0

100.0

I

50.0

25.0

25.0

25.0

75.0

0.0

0.0

0.0

0.0

50.0

100.0

S

0.0

0.0

0.0

25.0

25.0

0.0

75.0

0.0

0.0

0.0

0.0

Escherichia hermannii

1

R

100.0

100.0

0.0

0.0

0.0

100.0

0.0

100.0

100.0

0.0

100.0

100.0

I

0.0

0.0

100.0

0.0

0.0

0.0

0.0

0.0

0.0

100.0

0.0

S

0.0

0.0

0.0

100.0

100.0

0.0

100.0

0.0

0.0

0.0

0.0

Enterobacter cloacae

15

R

46.7

33.3

6.7

0.0

0.0

93.3

6.7

100.0

93.3

26.7

46.7

86.7

I

26.7

40.0

60.0

20.0

6.7

0.0

26.7

0.0

0.0

60.0

40.0

S

26.7

26.7

33.3

80.0

93.3

6.7

66.7

0.0

6.7

13.3

13.3

Klebsiella pneumoniae

15

R

20.0

20.0

26.7

0.0

0.0

66.7

46.7

80.0

60.0

26.7

40.0

60.0

I

20.0

20.0

46.7

26.7

26.7

0.0

20.0

0.0

0.0

20.0

26.7

S

60.0

60.0

26.7

73.3

73.3

33.3

33.3

20.0

40.0

53.3

33.3

Escherichia coli

13

R

7.7

0.0

23.1

0.0

0.0

53.8

46.2

76.9

7.7

0.0

30.8

0.0

I

0.0

0.0

7.7

15.4

0.0

0.0

23.1

0.0

7.7

0.0

15.4

S

92.3

100.0

69.2

84.6

100.0

46.2

30.8

23.1

84.6

100.0

53.8

Overall

70

R

50.0

38.6

47.1

2.9

0.0

72.9

45.7

91.4

72.9

28.6

51.4

62.9

I

12.9

24.3

27.1

21.4

24.3

1.4

21.4

0.0

1.4

37.1

28.6

S

37.1

37.1

25.7

75.7

75.7

25.7

32.9

8.6

25.7

34.3

20.0

  1. aDisk diffusion testing using the following antibiotics: ATM aztreonam, CAZ ceftazidime, CIP ciprofloxacin, IMP imipenem, TGC tigecycline, C chloramphenicol, D doxycycline, G sulfisoxazole, GM gentamicin, K kanamycin, SAM ampicillin/sulbactam. R resistant, I intermediate, and S sensitive phenotypes were determined based on CLSI criteria